Imexpharm Corporation

IMP

VN000000IMP0

Pharmaceuticals

End-of-day quote Ho Chi Minh S.E. Other stock markets 18:00:00 2024-06-10 EDT			5-day change	1st Jan Change
70,700 ^VND	+1.43%		+2.61%	+24.91%

05-27	Imexpharm Corporation Appoints Tnrong Minh Hung, A Non-Executive Member of the Board of Directors, as A Member of the Audit Committee Under the Board of Directors	CI
04-19	Imexpharm Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Imexpharm Pharmaceutical Appoints Nguyen Quoc Dinh as Chairman

May 22, 2013

Imexpharm Pharmaceutical announced that it has appointed Nguyen Quoc Dinh as Chairman. The effective date is May 22, 2013.

Latest news about Imexpharm Corporation

Imexpharm Corporation Appoints Tnrong Minh Hung, A Non-Executive Member of the Board of Directors, as A Member of the Audit Committee Under the Board of Directors	05-27	CI
Imexpharm Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024	04-18	CI
Imexpharm Corporation Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	01-19	CI
Imexpharm Corporation Reports Earnings Results for the Full Year Ended December 31, 2023	01-19	CI
Imexpharm Corporation Approves Election of Hoang Duc Hung as an Independent Member of the Board of Directors	12-19	CI
Imexpharm Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	23-10-18	CI
Imexpharm Corporation Announces Dividend, Payable on October 20, 2023	23-09-18	CI
Imexpharm Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-07-18	CI
Imexpharm Corporation Appoints Chun Chaerhan as Chairperson of the Board of Directors	23-05-04	CI
Imexpharm Corporation Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-18	CI
Imexpharm Corporation Reports Earnings Results for the Full Year Ended December 31, 2022	23-01-17	CI
Imexpharm Corporation Reports Earnings Results for the Fourth Quarter Ended December 31, 2022	23-01-17	CI
Imexpharm Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-10-18	CI
Imexpharm Corporation announced that it has received funding from SK Group Ltd.	22-08-24	CI
Imexpharm Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-07-18	CI
Imexpharm Corporation Announces Personnel Change	22-05-30	CI
Imexpharm Corporation Announces Cash Dividend for 2021, Payable on June 24, 2022	22-05-13	CI
Imexpharm Corporation Reports Earnings Results for the First Quarter Ended March 31, 2022	22-04-18	CI
Imexpharm Corporation Reports Earnings Results for the Fourth Quarter Ended December 31, 2021	22-01-20	CI
Imexpharm Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	21-10-18	CI
Imexpharm Corporation Reports Earnings Results for the Second Quarter Ended June 30, 2021	21-07-20	CI
Imexpharm Corporation Reports Earnings Results for the First Quarter Ended March 31, 2021	21-04-18	CI
Imexpharm Corporation Reports Earnings Results for the Fourth Quarter Ended December 31, 2020	21-01-19	CI
Imexpharm Corporation Reports Earnings Results for the Nine Months of 2020	20-10-29	CI
Imexpharm Corporation Provides Earnings Guidance for the Fourth Quarter and Full Year of 2020	20-10-29	CI

Imexpharm Corporation is a Vietnam-based company engaged in the pharmaceutical industry. The Company manufactures, imports, exports and trades pharmaceutical products, antiseptics, traditional medicine, medical equipment and supplies, cosmetics, supplemental food and drinks. It is also involved in the provision of packaging services and warehousing services for pharmaceutical storage purposes. In addition, the Company is involved in medicinal herb cultivation.

Sector

Pharmaceuticals

More about the company

Income Statement Evolution

More financial data

Ratings for Imexpharm Corporation

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

70,700 VND

Average target price

75,733 VND

Spread / Average Target

+7.12%

Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

	1st Jan change	Capi.
IMEXPHARM CORPORATION	+24.91%	195M
ELI LILLY AND COMPANY	+48.53%	780B
NOVO NORDISK A/S	+41.76%	627B
JOHNSON & JOHNSON	-6.37%	353B
MERCK & CO., INC.	+20.93%	334B
ABBVIE INC.	+8.21%	296B
ASTRAZENECA PLC	+18.02%	244B
ROCHE HOLDING AG	-1.10%	217B
NOVARTIS AG	+11.46%	214B
AMGEN INC.	+4.40%	161B

Other Pharmaceuticals

Imexpharm Corporation

Equities

IMP

VN000000IMP0

Pharmaceuticals

Imexpharm Pharmaceutical Appoints Nguyen Quoc Dinh as Chairman

Latest news about Imexpharm Corporation

Chart Imexpharm Corporation

Company Profile

Income Statement Evolution

Ratings for Imexpharm Corporation

Analysts' Consensus

EPS Revisions

Annual profits - Rate of surprise

Sector Other Pharmaceuticals